Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A thermally actuated 3D foldable bioelectronic interface for multimodal electrophysiological and cytokine profiling of human spinal cord organoids.

Biosensors & bioelectronics·2026
Same author

Hyperhidrosis Improved by Samhwangsasim-Tang: A Case Report.

Clinical, cosmetic and investigational dermatology·2026
Same author

Entanglement mortality associated with using plastic debris as nesting material in the Eurasian tree sparrow (Passer montanus).

Environmental science and pollution research international·2026
Same author

Unusual Presentation of Hyponatremia: Persistent Hiccups.

Electrolyte & blood pressure : E & BP·2026
Same author

Whole-genome sequencing reveals genetic diversity, population structure, and core collection construction in Korean peach (<i>Prunus persica</i>) germplasm.

Frontiers in plant science·2025
Same author

Impact of artificial feeding policies on space use and competition dynamics in overwintering hooded crane and goose populations.

PloS one·2025

Related Experiment Video

Updated: May 28, 2026

Optogenetic Activation of Afferent Pathways in Brain Slices and Modulation of Responses by Volatile Anesthetics
08:16

Optogenetic Activation of Afferent Pathways in Brain Slices and Modulation of Responses by Volatile Anesthetics

Published on: July 23, 2020

Is There a Relationship between Hyperkalemia and Propofol?

Ju-Hyun Lee1, Young-Sun Ko, Hyun-Jong Shin

  • 1Department of Internal Medicine, Hanyang University Guri Hospital, Guri, Korea.

Electrolyte & Blood Pressure : E & BP
|October 15, 2011
PubMed
Summary

Propofol, a common anesthetic, may cause severe hyperkalemia leading to cardiac arrest. This case highlights a potential link between propofol administration and life-threatening hyperkalemia, emphasizing the need for further investigation.

Keywords:
heart arresthyperkalemiapropofolpropofol infusion syndrome

Related Experiment Videos

Last Updated: May 28, 2026

Optogenetic Activation of Afferent Pathways in Brain Slices and Modulation of Responses by Volatile Anesthetics
08:16

Optogenetic Activation of Afferent Pathways in Brain Slices and Modulation of Responses by Volatile Anesthetics

Published on: July 23, 2020

Area of Science:

  • Anesthesiology
  • Toxicology
  • Cardiology

Background:

  • Propofol is a widely used intravenous anesthetic agent.
  • Cardiopulmonary arrest is a critical medical emergency.
  • Hyperkalemia is a condition characterized by elevated potassium levels in the blood.

Observation:

  • A 29-year-old female experienced sudden cardiopulmonary arrest immediately after a 100 mg intravenous bolus of propofol during a dilatation and curettage procedure.
  • The patient presented to the emergency room with severe hyperkalemia (9.1 mEq/L) and ventricular fibrillation.
  • Despite successful resuscitation and conversion to sinus rhythm, the patient unfortunately expired.

Findings:

  • Severe hyperkalemia induced by propofol was strongly suspected as the cause of death, given the temporal association and absence of other identified causes.
  • Literature review indicated that propofol-induced hyperkalemia is not well-documented.

Implications:

  • This case suggests a potential causal relationship between propofol administration and severe hyperkalemia.
  • Further research is warranted to explore the mechanisms and incidence of propofol-induced hyperkalemia.
  • Clinicians should be aware of this potential adverse effect of propofol, especially in susceptible individuals.